Vivani Medical, Inc. (VANI)Healthcare | Biotechnology | Alameda, United States | NasdaqCM
1.42 USD
+0.02
(1.429%)
⇧
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 1.41 -0.01 (-0.010%) ⇩ (Aug. 28, 2026, 7:30 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 1:08 a.m. EDT
The investment case here is defined by a stark disconnect between aggressive analyst targets and the company's deteriorating financial reality. While analysts project a mean price of $3.83, implying a massive recovery, the underlying business is bleeding cash with negative free cash flow and a return on equity of -220%. The stock has lost 98.5% of its value over the last nine years, and despite a recent uptick, it remains trapped in a multi-year downtrend where the market has consistently punished the asset. The lack of dividends and the heavy cash burn suggest this is a speculative vehicle reliant entirely on a successful merger or turnaround, rather than a value play. The recent insider buying provides a glimmer of confidence, but given the massive dilution potential and the company's inability to generate organic cash, this remains a high-risk gamble rather than a sound investment. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.129802 |
| AutoARIMA | 0.129830 |
| MSTL | 0.135945 |
| AutoTheta | 0.166916 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 34% |
| H-stat | 1.79 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.862 |
| Excess Kurtosis | -0.02 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 94.142 |
| Market Cap | 128,088,768 |
| Forward P/E | -4.06 |
| Beta | 3.28 |
| Previous Name | Second Sight Medical Products, Inc. |
| Website | https://www.vivani.com |
As of Aug. 22, 2026, 1:08 a.m. EDT: Speculators are positioning for a modest upside move, evidenced by significant open interest in out-of-the-money calls at the $2.00 strike across multiple expirations, which acts as a barrier for the stock to breach. Conversely, put activity is negligible, suggesting a lack of hedging demand or fear of immediate collapse. Implied volatility is elevated for the nearest expiration compared to further-out dates, indicating traders expect heightened uncertainty in the immediate term.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.20689654 |
| Address1 | 1,350 South Loop Road |
| All Time High | 576.48 |
| All Time Low | 0.754 |
| Ask | 1.81 |
| Ask Size | 2 |
| Average Analyst Rating | 1.3 - Strong Buy |
| Average Daily Volume10 Day | 226,800 |
| Average Daily Volume3 Month | 461,683 |
| Average Volume | 461,683 |
| Average Volume10Days | 226,800 |
| Beta | 3.282 |
| Bid | 1.01 |
| Bid Size | 2 |
| Book Value | 0.212 |
| City | Alameda |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.42 |
| Current Ratio | 3.249 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 1.43 |
| Day Low | 1.39 |
| Debt To Equity | 94.142 |
| Display Name | Vivani Medical |
| Dividend Date | 1,578,268,800 |
| Earnings Timestamp End | 1,794,513,600 |
| Earnings Timestamp Start | 1,794,513,600 |
| Ebitda | -26,879,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -4.69 |
| Enterprise Value | 126,050,768 |
| Eps Forward | -0.35 |
| Eps Trailing Twelve Months | -0.37 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.3373 |
| Fifty Day Average Change | 0.082700014 |
| Fifty Day Average Change Percent | 0.061841037 |
| Fifty Two Week Change Percent | 20.689655 |
| Fifty Two Week High | 1.92 |
| Fifty Two Week High Change | -0.5 |
| Fifty Two Week High Change Percent | -0.2604167 |
| Fifty Two Week Low | 0.923 |
| Fifty Two Week Low Change | 0.49699998 |
| Fifty Two Week Low Change Percent | 0.5384615 |
| Fifty Two Week Range | 0.923 - 1.92 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,416,407,400,000 |
| Float Shares | 38,860,508 |
| Forward Eps | -0.35 |
| Forward P E | -4.0571427 |
| Free Cashflow | -16,834,124 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 42 |
| Fullday Change | 0.02 |
| Fullday Change Percent | 1.42857 |
| Fullday Price | 1.41 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.55391 |
| Held Percent Institutions | 0.058930002 |
| Implied Shares Outstanding | 90,203,356 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,660,867,200 |
| Last Split Factor | 1:3 |
| Long Business Summary | Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases. Its pipeline includes NPM-139 for chronic weight management in patients who are obese or overweight; NPM-133 a semaglutide implant for the treatment of patients with type 2 diabetes; NPM-115, an exenatide implant candidate for chronic weight management in patients who are obese or overweight; and OKV-119, an exenatide implant for the treatment of obesity and diabetes in companion animals, including cats and dogs. The company is headquartered in Alameda, California. |
| Long Name | Vivani Medical, Inc. |
| Market | us_market |
| Market Cap | 128,088,768 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_260862802 |
| Most Recent Quarter | 1,782,777,600 |
| Name Change Date | 2,026-08-29 |
| Net Income To Common | -26,313,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 126,284,698 |
| Number Of Analyst Opinions | 3 |
| Open | 1.41 |
| Operating Cashflow | -25,301,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 415 506 8462 |
| Post Market Change | -0.00999999 |
| Post Market Change Percent | -0.7042247 |
| Post Market Price | 1.41 |
| Post Market Time | 1,787,959,806 |
| Prev Name | Second Sight Medical Products, Inc. |
| Previous Close | 1.4 |
| Price Hint | 4 |
| Price To Book | 6.698113 |
| Profit Margins | 0.0 |
| Quick Ratio | 3.094 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.33333 |
| Region | US |
| Regular Market Change | 0.02 |
| Regular Market Change Percent | 1.42857 |
| Regular Market Day High | 1.43 |
| Regular Market Day Low | 1.39 |
| Regular Market Day Range | 1.39 - 1.43 |
| Regular Market Open | 1.41 |
| Regular Market Previous Close | 1.4 |
| Regular Market Price | 1.42 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 162,854 |
| Return On Assets | -0.48474997 |
| Return On Equity | -2.20405 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 90,203,356 |
| Shares Percent Shares Out | 0.0058999998 |
| Shares Short | 530,090 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 354,370 |
| Short Name | Vivani Medical, Inc. |
| Short Percent Of Float | 0.0112 |
| Short Ratio | 2.73 |
| Source Interval | 15 |
| State | CA |
| Symbol | VANI |
| Target High Price | 4.0 |
| Target Low Price | 3.5 |
| Target Mean Price | 3.83333 |
| Target Median Price | 4.0 |
| Total Cash | 19,894,000 |
| Total Cash Per Share | 0.221 |
| Total Debt | 17,856,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.37 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.28534 |
| Two Hundred Day Average Change | 0.13466 |
| Two Hundred Day Average Change Percent | 0.10476606 |
| Type Disp | Equity |
| Volume | 162,854 |
| Website | https://www.vivani.com |
| Zip | 94,502 |